Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $6840.0.

  • Coya Therapeutics' Depreciation & Amortization (CF) fell 1.46% to $6840.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27360.0, marking a year-over-year change of 0.37%. This contributed to the annual value of $27361.0 for FY2024, which is 0.0% changed from last year.
  • Per Coya Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $6840.0 for Q3 2025, which was down 1.46% from $6840.0 recorded in Q2 2025.
  • Over the past 5 years, Coya Therapeutics' Depreciation & Amortization (CF) peaked at $12455.0 during Q3 2022, and registered a low of $4033.0 during Q1 2022.
  • For the 4-year period, Coya Therapeutics' Depreciation & Amortization (CF) averaged around $6840.2, with its median value being $6840.0 (2022).
  • Data for Coya Therapeutics' Depreciation & Amortization (CF) shows a peak YoY increase of 6960.08% (in 2023) and a maximum YoY decrease of 4507.43% (in 2023) over the last 5 years.
  • Over the past 4 years, Coya Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then changed by 0.0% to $6840.0 in 2025.
  • Its Depreciation & Amortization (CF) was $6840.0 in Q3 2025, compared to $6840.0 in Q2 2025 and $6840.0 in Q1 2025.